Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veerman

Showing results (891-900 of 941) with videos related to

Pageof 95
Sort By:
British Journal of Clinical Pharmacology|April 26, 2021
Prior use of therapeutic anticoagulation does not protect against COVID-19 related clinical outcomes in hospitalized patients: A propensity score-matched cohort studyJanneke P Spiegelenberg, Marleen M H J van Gelder, Martje L Maas, et al.
Journal of Robotic Surgery|July 12, 2022
Development and clinical applicability of MRI-based 3D prostate models in the planning of nerve-sparing robot-assisted radical prostatectomyHans Veerman, Thierry N Boellaard, Jari A van der Eijk, et al.
European Urology Focus|April 17, 2024
A Systematic Review on the Impact of Quality Assurance Programs on Outcomes after Radical ProstatectomySophia H van der Graaf, Marinus J Hagens, Hans Veerman, et al.
Nature Communications|July 30, 2021
BRCA2 binding through a cryptic repeated motif to HSF2BP oligomers does not impact meiotic recombinationRania Ghouil, Simona Miron, Lieke Koornneef, et al.
Haematologica|September 8, 2006
The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocolsMartine van Grotel, Jules P P Meijerink, H Berna Beverloo, et al.
Bone|November 30, 2013
Bone mineral density at diagnosis determines fracture rate in children with acute lymphoblastic leukemia treated according to the DCOG-ALL9 protocolMariël L te Winkel, Rob Pieters, Wim C J Hop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2003
Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemiaM L Den Boer, D O Harms, R Pieters, et al.
World Journal of Urology|January 12, 2026
Second-look transurethral resection in high-grade Ta non-muscle invasive bladder cancerSophie Régnier, Pierre-Etienne Gabriel, Idir Ouzaid, et al.
BMC Cancer|October 30, 2016
Living well after breast cancer randomized controlled trial protocol: evaluating a telephone-delivered weight loss intervention versus usual care in women following treatment for breast cancerMarina M Reeves, Caroline O Terranova, Jane M Erickson, et al.
World Journal of Urology|May 13, 2026
Multi-institutional external validation of the European risk classification for high-grade Ta non-muscle-invasive bladder cancerManon Cournède, Pierre-Etienne Gabriel, Marine Lottin, et al.
Pageof 95

Showing results (891-900 of 941) with videos related to

Sort By:
Pageof 95
British Journal of Clinical Pharmacology|April 26, 2021
Prior use of therapeutic anticoagulation does not protect against COVID-19 related clinical outcomes in hospitalized patients: A propensity score-matched cohort studyJanneke P Spiegelenberg, Marleen M H J van Gelder, Martje L Maas, et al.
Journal of Robotic Surgery|July 12, 2022
Development and clinical applicability of MRI-based 3D prostate models in the planning of nerve-sparing robot-assisted radical prostatectomyHans Veerman, Thierry N Boellaard, Jari A van der Eijk, et al.
European Urology Focus|April 17, 2024
A Systematic Review on the Impact of Quality Assurance Programs on Outcomes after Radical ProstatectomySophia H van der Graaf, Marinus J Hagens, Hans Veerman, et al.
Nature Communications|July 30, 2021
BRCA2 binding through a cryptic repeated motif to HSF2BP oligomers does not impact meiotic recombinationRania Ghouil, Simona Miron, Lieke Koornneef, et al.
Haematologica|September 8, 2006
The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocolsMartine van Grotel, Jules P P Meijerink, H Berna Beverloo, et al.
Bone|November 30, 2013
Bone mineral density at diagnosis determines fracture rate in children with acute lymphoblastic leukemia treated according to the DCOG-ALL9 protocolMariël L te Winkel, Rob Pieters, Wim C J Hop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2003
Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemiaM L Den Boer, D O Harms, R Pieters, et al.
World Journal of Urology|January 12, 2026
Second-look transurethral resection in high-grade Ta non-muscle invasive bladder cancerSophie Régnier, Pierre-Etienne Gabriel, Idir Ouzaid, et al.
BMC Cancer|October 30, 2016
Living well after breast cancer randomized controlled trial protocol: evaluating a telephone-delivered weight loss intervention versus usual care in women following treatment for breast cancerMarina M Reeves, Caroline O Terranova, Jane M Erickson, et al.
World Journal of Urology|May 13, 2026
Multi-institutional external validation of the European risk classification for high-grade Ta non-muscle-invasive bladder cancerManon Cournède, Pierre-Etienne Gabriel, Marine Lottin, et al.
Pageof 95